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Summary 
 
Williams Syndrome (WS) is a complex 
neurodevelopmental disorder characterized by 
vascular and heart disease, mental retardation, 
characteristic facial features, and characteristic 
personality. WS, which is usually sporadic, affects 
approximately 1 in 20,000 live births and is caused 
by a particular deletion of about 1.5 Mb of 
chromosome 7q11.23. My lab has shed light on the 
anatomical and cognitive basis for WS. While WS 
patients have cognitive gifts, such as notable 
linguistic abilities, they also have deficits, such as 
visuospatial deficits. WS patients also show 
significant anatomical differences, with a reduced 
perimeter of the corpus collosum and amygdalar 
nuclei. The major current goal in the field is to 
connect the genetic basis to these anatomical and 
cognitive differences. About 28 genes are deleted in 
WS; four such genes are Elastin, Lim kinase, WSTF 
and GTF21..  An elastin deletion results in 
supravalvular aortic sclerosis (SVAS), which is 
common in WS patients. Lim kinase absence 
affects actin polymerization and lamellipodia 
formation and may regulate abnormal synaptic 
development. WSTF deletion results in 
misregulation of chromatin remodeling and this 
may have profound consequences during 
development. GTF absence explains the facial and 
skull abnormalities in WS. The impact of other gene 
deletions is poorly understood; thus, future work 
continues to focus on the relationship between 
genetics, the brain and cognition in relation to WS 
syndrome. 
             
Introduction 
 
A rare, generally sporadic neurodevelopmental disorder 
was first described by Williams et al in 1961. Williams 
and colleagues described a group of individuals with 
growth deficiencies, supravalvular aortic stenosis, and 
atypical facial features
1
.  Beuren et al then described 
individuals with similar characteristics as well an 
amicable personality and some dental irregularities
1
. 
Collectively, these characteristics describe individuals 
with Williams-Beuren Syndrome (Williams Syndrome).
 Along with the characteristics described by 
Williams and Beuren, individuals with this rare disorder  
have mild to moderate mental retardation, sensitivity to 
sound, exhibit hypersociability, and commonly have 
infantile hypercalcaemia, gastrointestinal problems, 
hypertension, and ADHD
1-3
.  In addition to these  
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features, Williams Syndrome patients also display 
significant anatomical differences
3
. While WS patients 
exhibit significant strengths in short-term memory and 
language, they also exhibit deficiencies, especially in 
visuospatial cognition. We have done several studies to 
investigate the neuroanatomical features of the 
syndrome. We have also examined its behavioral and 
developmental aspects, and their respective 
contributions to WS. 
Williams syndrome is thought to affect 
between approximately 1 in 7,500 to 1 in 20,000 
people. WS is caused by the deletion of ~1.6 Mb of 
chromosome 7q11.23 
1-3
. This deletion is caused by an 
unequal crossing over of repeats during mitosis and 
results in the hemizygotic deletion of about 28 genes
3
. 
Many of these genes have been investigated and 
characterized.  Four genes, elastin (ELN), Lim Kinase 
(LimK), WSTF and GTF, and their effects on WS 
individuals will be discussed in this paper. While my 
lab’s focus is the anatomical and cognitive aspects of 
WS, the goal of this review is to elucidate the link 
between cognition, the brain, and genes. 
 
Williams syndrome and Downs Syndrome 
 
Linguistic Abilities     
We have done previous studies investigating the 
various cognitive, anatomical, behavioral, and biological 
aspects of different developmental disorders
4-6
. While 
we know some of the cognitive facets of the disorder 
many other aspects of the disorder, such as a specific 
profile for Williams syndrome, remain to be clarified. 
 Our previous research has shown that 
Williams Syndrome patients show notable strengths in 
language and facial processing but weaknesses in their 
special cognitive abilities. In contrast, Down syndrome 
patients have significant cognitive, language, and 
visuospatial deficits
4-6
. The difference in cognitive 
abilities of DS and WS make it of interest to us to 
compare the two groups. Both WS and DS patients 
have been shown to have a delayed onset of first 
words
4
. Although both groups are delayed when 
compared to normally developing children, WS patients 
overcome this extreme delay in words, while DS 
patients do not.  Our early research focused on the 
comparison between IQ matched DS and WS, which 
would allow us to begin to understand the systems that 
regulate language and cognitive abilities
4-6
.     
 A comparison of the two groups showed that 
WS patients have conserved semantic abilities. After 
hearing a word, WS patients were more readily able to 
choose the correct picture out of a group.  In this same 
task all DS patients fell below their mental age 
equivalents. When being tested at a different task, this 
one requiring a verbal cue and a verbal response, WS 
patients also produce an increased amount of words, 
including unusual and uncommon words, showing 
greater word fluency when compared to DS patients 
4-6
.  
Together these results show that not only do WS 
patients show an increased lexical semantic ability, but 
they also show increased grammatical abilities when 
compared to DS patients. Some of the differences 
between DS and WS were established. A better 
cognitive profile for WS has been establish, but the 
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direct cause for the cognitive differences in DS and WS 
has yet to be determined. 
 
Sociability and Language 
We have shown that WS patients exhibit significant 
abilities in some cognitive aspects. Another aspect of 
the WS profile to be studied is their sociable 
personality. WS patients show an excessively social 
behavior, often times being overly talkative and fearless 
of social interactions
7
. Hypersociability may be a 
phenotype that also differentiates WS patients from 
other disorders. Therefore, we thought it relevant to 
study hypersociability and its neurological and genetic 
basis for this syndrome.    
Our experiments showed that WS patients 
use language as a way to engage their audience
7
. Not 
only do WS patients use a longer and more complex 
language, they also tend to use more expressive 
language, such as voice changes, sound effects, 
character speech, voice lengthening, and other 
linguistic devices. This excessive trend is significantly 
different from DS and normal control patients
7
. 
Collectively, our results indicated that despite language 
delays WS patients use their language for social 
purposes
7
. These finding allowed us to better 
understand this aspect of the WS profile.  
 
Spatial Cognition     
While we have shown that WS patients have increased 
linguistic abilities, we also found WS patients have 
strong deficits in spatial cognition
4-6
.  We used several 
task in order to test and compare the visuospatial 
cognitive abilities of our WS and DS patients. In a block 
design task both groups are unsuccessful but in 
different ways. WS patients make designs that show 
non-joined fragments, while DS patients have joined 
blocks but poor internal organization.  In a task 
requiring a freehand drawing, we saw that WS patients 
make illogical drawings. This occurred even as the 
patients talked their way through the drawing process. 
DS patients in contrast draw logical drawings, but 
demonstrate poor internal organization. A third task 
requiring visuospatial processing was administered. 
This one required the subject to look at an angled line 
and match it to a line found within a group. Both WS 
and DS patients performed poorly
4-6
. This finding was 
not surprising as it further demonstrated the 
visuospatial deficits previously found in WS patients 
6
.  
 
Face Recognition   
Thus far, our investigations showed that WS patients 
have strong deficits in some aspects of special 
cognition including block design, drawing special 
transformations, and spatial memory
6
. Surprisingly, one 
aspect of visuospatial cognition, face processing, and 
recognition was found to be relatively spared in WS 
patients.      
Our initial study compared DS patients to WS 
patients in order to better understand the strengths and 
weaknesses generated by this syndrome
4-6
. The 
Benton Facial Recognition test was used in order to 
evaluate the facial recognition abilities of WS and DS 
patients. This test requires the patients to look at a 
photograph and then choose the matching face from a 
group of six photographs. Our initial findings suggested 
that WS patients have a better ability to discriminate 
between faces. All WS patient tested, between the ages 
of 10 and 17, performed at or above the level of an 
average adult. DS patients, unlike WS patients, show a 
severe inability in this visuospatial task.   
 Later studies verified our previous findings
7
. 
The Benton Upright Face Task, The Warrington Face 
Memory Test, and the Mooney Closure Test, three 
distinct face processing tasks, showed similar results
4
. 
Although variations in lighting, shadow, and orientation 
were occurred throughout the tasks all WS patients 
performed at an average level when compared to 
controls and performed significantly better than DS 
patients
4-6
.      
It then became of interest to us to investigate 
the differences in accuracy and timing of facial 
recognition. Investigating these aspects, along with our 
previous findings, would allow us to explore the 
cognitive profile of WS patients. WS patients, like the 
normal control, were typically faster and more accurate 
at identifying matched versus mismatched photographs. 
Furthermore, WS patients like normal controls, were 
faster and more accurate when processing upright 
versus inverted faces
8
. This was important as we 
wanted to explore the hypothesis that there may be two 
different manners of processing upright and inverted 
data.  Farah et al (1998) found in recent studies that 
upright facial recognition require processing of faces as 
a whole, while inverted pictures require the processing 
of parts of a picture
8
. The differences in timing and 
accuracy found in our recent studies may be linked to 
this data. 
 
Cognition: Three Trajectories   
Through various studies we acquired an understanding 
of the differences in cognitive abilities between WS and 
DS patients.  We have established that DS patients 
have below average face recognition, spatial and lexical 
knowledge. Their below average achievement as seen 
from an early age tends to not increase as patients get 
older
4, 6
.       
WS patients in contrast, begin with an 
exceedingly low vocabulary and lexical knowledge, but 
these abilities are significantly strengthened with age. 
When examining spatial cognition WS patients start 
with below average abilities, and their performances 
remain substandard with age.  The exact reasons 
between the differences in the cognitive profiles seen in 
WS and DS are yet to be elucidated.  Our studies have 
helped elucidate the strengths and weaknesses of WS 
patients and have helped in improving the 
understanding of the cognitive profile of WS.  
 The next major goal is to link the cognitive, 
morphological, and physiological aspects of WS, in 
order to shed light on the relationships between 
cognition and the brain. 
 
The Anatomy of Williams Syndrome   
Our effort to understand the possible underlying 
anatomical difference that may be linked to the 
differences in cognitive profiles of WS and DS lead to 
our early anatomy research. We focused on the 
anatomical differences between WS and DS patients.
 In contrast to the DS patient findings, the 
corpus collosum of WS patients was found to resemble 
control specimen with no changes in volume. Although 
there is a similar collosum volume, WS patients had a 
reduced corpus collosum perimeter
9
. Subsequent 
examination of WS brain reflected a difference in the 
bend angle of the corpus collosum with the angle being 
larger than controls
10
. These shape differences, we 
believe are a result of parieto-occipital region variation. 
Our lab’s preliminary studies, which show 
morphological differences,  showed a decreased  
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Figure 1. The Deletions in WS. WS is caused by the 
hemizygotic deletion of about 28 genes in human chromosome 
7q11.23. The genes elastin, LIM-kinase, WSTF and GTF are 
known to be four of the 28 genes in the ~1.5 Mb deleted region. 
(Adapted from Smoot et. al.  2005, Tipney et al. 2004, and 
Meyer-Lindenberg et al. 2006) 
 
splenium size. This size change is significant as it 
would help explain the visuospatial deficits since the 
splenium connects bilateral parieto-occipital regions
10
.
 Collectively, the WS corpus collosum 
findings, which are generally similar to controls, may be 
an explanation for the preservation of frontal lobe 
structure and better conserved frontal lobe function
9
. It 
is our belief that the preserved linguistic abilities seen in 
WS patients may result from the sparing of frontal and 
cerebellar structures, as well as the normal 
development of limbic structures in WS. 
 
Limbic Structures     
Our studies showed that limbic structures, such as the 
uncus, amygdala, and hippocampus showed conserved 
sizes. Intriguingly, studies done by Meyer-Lindenberg et 
al
11
, also focused on a limbic structure, but their 
investigation focused primarily on functional 
neuroimaging. Their results showed that there is 
reduced reactivity in the amygdala of WS patients to 
threatening images, but also showed an increased 
reactivity to threatening scenes compared to normal 
control. The reduced activation of the amygdala in the 
presence of a threatening face may contribute to WS 
patients’ diminished fear of strangers
11
. The increased 
reactivity of the amygdala to social situations is of 
particular importance as it may be a possible 
explanation for the increased anxiety often seen in WS 
patients
11
.  
     
Genetics 
 
Chromosomal Deletion 
The hemizygotic deletion of chromosome 7q11.23 
results in the deletion of about 28 genes, including ELN, 
LimK, WSTF and GTF
1-3
 (Figure 1). Many of these 
genes have now been characterized, and the result of 
their deletion is understood. While our research focuses 
on the cognitive, behavioral, and anatomical aspects of 
the disease it is important to understand the underlying 
genetic explanations for the disease. In order to better 
understand this aspect of the disease, we use other 
research in the field to explain the function and deletion 
of the previously mentioned four genes. 
Among the constituents of the extracellular 
matrix of arteries is elastin. Li et al had previously 
shown that the lack of one allele of elastin causes an 
arterial disease, supravavular aortic stenosis 
(SVAS)
12,13
. In order to investigate elastin’s role in the 
development of arteries as well as its role in SVAS, 
various knockout studies were done.   
 Initial studies demonstrate that the deletion of 
elastin reduces the amount of elastin mRNA and 
protein. Also shown was that an elastin deficiency had 
a profound effect on the development of arteries
12
. 
While there is no difference seen between knockout 
mice (ELN
-/-
) and control mice (ELN
+/+
) aortae before 
embryonic day 15.5, there are significant changes in 
ELN
-/-
 aortic diameter and cell count thereafter. Cross-
sections of different developmental stages show a 
significant increase in the amount of cells in the arteries 
of ELN
-/-
 as well as reduced artery size. Results 
indicated that while there was an increase in arterial 
wall thickness, as a result of increased lamellar units
13,
 
there was also a reduction in inner arterial diameter.  
This data suggests that the development of arteries in 
mice lacking elastin is atypical
12
.  
 Further studies were done in order to better 
understand the reason for subendothelial accumulation 
of smooth muscles cells (SMCs). To do this, cells were 
stained with antisera containing Proliferating-cell 
nuclear antigen (PCNA)
 12
. Results indicated that 85% 
of ELN
-/-
 cells stained for the antigen versus 35% of 
ELN
+/+ 
cells. This indicates that there is an increased 
cell proliferation in elastin deficient mice
12
. This 
increased proliferation was later linked to the reduced 
elastin deposition seen in SVAS patients
13
.  
 Through various studies, a link has been 
made between the reduced ELN deposition and the 
deficiency of ELN
14
. Studies have also shown, through 
the use of knock-out mice, that the lack of elastin is a 
direct cause of SVAS
13
. Collectively, the results of 
elastin studies show that elastin is necessary for normal 
arterial development and SMC proliferation and that the 
deletion of this gene results in the SVAS, commonly 
seen in WS patients.  
 
LIM- kinase     
In order to understand the effect of the deletion of LIM-
kinase (LIMK-1) it was essential to first understand its’ 
function. Studies first focused on the role of LIMK-1 in 
actin reorganization.  It was first established that LIMK-
1 associated with actin. This was done with the use of 
rat brain, a LIMK-1 fusion protein, and immunoblotting. 
Sequencing indicated that LIMK-1 associated with 
actin
15
. Yang et al believed that the previously 
established association may have been involved in 
regulation of actin cytoskeleton organization. This was 
later established, as experiments showed that LIMK-1 
tagged cells show actin reorganization.
15
  
 
Pathways, Pathways, Pathways   
Once it had been demonstrated that there was an 
interaction between actin and LIMK-1 and that this 
association resulted in the reorganization of actin, it 
became of interest to determine the mechanism by 
which changes in actin organization occurred. In vitro 
studies showed that LIMK-1 phosphorylated colifin and  
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Figure 2. Lim Kinase Pathway In Williams Syndrome. Rho, a small GTPase, activates ROCK, a protein kinase. The activation of ROCK 
leads to the phosphorylation and subsequent inactivation of colifin, an actin binding protein required for actin filament depolymerization. The 
inactivation leads to increase actin accumulation and lamellipodia formation. Rac, a small GTPase increases LimK autophoshorylation, 
resulting in lamellipodia formation. In WS, LimK is deleted, resulting in a decrease in lamellipodia formation.  
 
proteins with depolymerizing and actin-binding 
abilities
15
. The phosphorylation of colifin thereby 
inactivated it, completely hindering colifin’s 
depolymerization activities
15
.    
It was also known that Rac, a small GTPase, 
was involved in regulation of actin cytoskeleton 
reorganization
15
. Yang et al therefore became 
interested in determining if LIMK was involved in the 
Rac-induced signaling pathway for actin organization
15
. 
It was determined that Rac induced lamellipodia 
formation through the activation of LIMK-1.  These 
finding were confirmed by Arber et al, who established 
that Rac leads to an increased autophosphorylation of  
LIMK; increased amount of LIMK-1 causes the 
phosphorylation and subsequent inactivation of colifin, 
which then lead to the accumulation of actin filaments
16
 
 While one mechanism for the actin 
cytoskeleton had been clarified a second mechanism, 
this one involving a GTPase Rho and a Rho-associated 
kinase ROCK, had yet to be clarified. In an in vitro 
study Maekawa et al show that LIMK-1 activity was 
greatly increased in the presence of a dominant active 
ROCK mutant (ROCK1) and a dominant inactive Rac 
mutant (N17-Rac)
 1
. These results indicated that there 
was, in fact, ROCK activation of Lim kinase. 
 In conjunction, the results of these studies 
showed a pathway that now included Rho and ROCK, 
where Rho activated ROCK, leading to the 
phosphorylation and subsequent inactivation of colifin. 
The inactivation of colifin then lead to the inhibition of 
actin depolymerization, thereby leading to its 
accumulation
17 
(Figure 2).    
 The mechanism by which Lim kinase 
regulates actin organization had now been 
demonstrated in vivo. Few studies had been done to 
observe actin activity in Lim kinase knockout mice. 
Furthermore, the link between the deletion of LIMK-1 
and the WS profile had yet to be established. Meng et 
al proposed that LIMK-1 was involved in brain fuction 
through regulation of actin
18
.    
 Knockout out mice were generated in order to 
investigate this hypothesis. It was shown that the 
organization of the actin cytoskeleton of neurons was 
abnormal in knockout mice. This distribution 
abnormality was especially evident in neuron dendrites, 
where morphology of spines was also significantly 
affected
18
.  Knockout mice also showed a reduction in 
the size of their growth cones.  These results indicate 
that LIMK-1 is necessary for the proper organization 
and distribution of actin filaments in neurons as well as 
for the maintenance of spine morphology in neuronal 
dendrites
18
.  Furthermore, later studies demonstrated 
that LIMK-1 is linked to changes in fear response and 
spatial learning. 
WS patients are characterized by impaired 
cognitive ability. These studies have shown that LIMK-1 
deletions are both responsible for abnormal neuronal 
actin organization. These finding lead researchers in 
the field to believe the affects that LIMK-1 has on 
neurons and actin organization may be linked to the 
cognitive impairments seen in WS patients, although 
there is some disagreement on this issue. Further 
research is needed in order to confirm this hypothesis.  
 
WSTF Deletion   
Williams Syndrome Transcription factor (WSTF) is the 
product of WSCR9 genes. This gene, previously known 
as WCRF, encodes a 1425 amino acid protein and is 
deleted in WS patients
19, 20
. Studies have shown 
through the use of antibodies and immunoprecipitation 
that WSTF and SNF2I, an isotope ISWI, form a 
chromosome remodelling complex, WICH 
21
. Results 
indicate that this WSTF-ISWI remodelling complex is 
partly responsible for the change of irregular chromatin 
to a regular chromosomal array.    
 Along with WSTF’s role in reconfiguring 
chromatin, a second important role was also elucidated. 
Studies showed that WSTF localizes with M31, a 
marker for pericentromeric heterochromatin
19
. WSTF 
was also shown to accumulate at the foci of replicating 
heterochromatin
21
.  Bozhenok et al hypothesized that 
the accumulation of WSTF at pericentromeric 
heterochromatin may point to a possible role for WSTF 
in the replication of condensed heterochromatin or a 
role in the assembly of heterochromatin after replication 
has occurred. They also suggest that given 
pericentromeric heterochromatin’s role in chromosome 
stability, WSTF’s deletion may affect cell’s survival
21
. 
 
WICH: A chromatin remodelling complex 
WICH, a multi-protein complex that contains WSTF and 
SNF2I, is now known to be part of a larger complex. 
This larger complex contains nuclear actin and myosin 
1 (NM1), a regulator of gene transcription
22
. It is also 
now known that NM1 is found in the nucleus and is 
required for the transcription of RNA polymerases. 
Therefore, comprehending the role of WICH and NM1 
may elucidate new roles for WSTFs.   
 A recent study has shown that NM1 is 
localized within the nucleoli of cells and that it is 
 99 
required for polymerase 1 transcription. The previous 
finding was established as antibodies for NM1 inhibited 
the transcription of polymerase 1 
22
.   
 NM1, WSTF, and SNF2I were also shown to 
associate with rDNA and promote the synthesis of pre-
rRNA. Given the complex’s ability to promote the 
synthesis of pre-rRNA, it was thought relevant to 
investigate the effect of WSTF depletion through RNA 
interference. The depletion of WSTF resulted in the 
inhibition of pre-rRNA synthesis
22
.  This finding 
suggests a new role for WSTF that was not previously 
established.     
 The combined findings of various studies 
suggest that the deletion of WSTF leads to some of the 
phenotypes of WS. More research is still need to be 
done to define the exact outcome of the WSTF deletion.   
 
The GTFIRD1Contribution  
GTFIRD1 was identified, characterized, and found to be 
in the WS deletion region
23
. This gene was known to be 
involved in the development and differentiation of 
tissues. GTFRD1 was thought to contribute to the 
phenotype of WS, but this hypothesis was not 
thoroughly tested until recently. The role of GTFIRD1 
was investigated by examining gtfird1 mice. It was 
shown that GTFIRD1 null mutants exhibit significant 
weight loss relative to normal controls and growth 
deficiencies. Null mutant mice also exhibit misaligned 
jaws, dysmorphic faces, and shorter snots
24
.  
 The previously stated findings suggested that 
the depletion of GTFIRD1, through a homozygous 
deletion, results in craniofacial abnormalities similar to 
those found in WS patients. GTFIRD1 was known to be 
a positive regulator of goosecoid, a transcription factor 
involved in development
24
. This may suggest that there 
is a mechanism involving GTFIRD1 and goosecoid that 
is responsible for proper jaw and skull development
24
. 
This suggestion remains to be clarified.  
 
Conclusion 
     
Our studies have attempted to elucidate the cognitive, 
behavioral, and anatomical differences between Down 
syndrome and Williams Syndrome patients. Research 
in the field has also made advances in understanding 
the genetic aspects of WS. We have made many 
advances in the field, as we now have a better 
understanding of the behavioral, cognitive, and 
anatomical aspects related to the disease. What is yet 
to be clarified is the specific reasons for all the 
characteristics seen in WS and the effects of all gene 
deletions. It is our future goal to be able to fully 
understand the link between cognition, the brain, and 
genes.   
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